Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Scientific Reports|July 27, 2022
The prevalence and natural history of hepatic cysts examined by ultrasound: a health checkup population retrospective cohort studyKota Tsuruya, Yasuhiro Nishizaki, Masayuki Tatemichi, et al.
Cancers|October 27, 2020
Hypothyroidism is a Predictive Factor for Better Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Undergoing Lenvatinib TherapyMasako Shomura, Haruka Okabe, Emi Sato, et al.
Plos One|November 13, 2020
Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patientsShunji Hirose, Koshi Matsumoto, Masayuki Tatemichi, et al.
Cancers|November 9, 2024
Impact of Atezolizumab + Bevacizumab Therapy on Health-Related Quality of Life in Patients with Advanced Hepatocellular CarcinomaMasako Shomura, Haruka Okabe, Maya Sakakibara, et al.
Clinical Drug Investigation|October 5, 2018
Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory AscitesYoshitaka Arase, Tatehiro Kagawa, Kota Tsuruya, et al.
The Tokai Journal of Experimental and Clinical Medicine|August 25, 2024
An Adult Case of Benign Recurrent Intrahepatic Cholestasis Due to MYO5B DeficiencyYusuke Mishima, Kota Tsuruya, Yosuke Tazawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 20, 2026
Rare Variants in PFIC-Related Genes Among Adults With Intrahepatic CholestasisShunji Hirose, Kota Tsuruya, Yusuke Mishima, et al.
The Tokai Journal of Experimental and Clinical Medicine|July 8, 2022
Antiviral Therapy for Patients Chronically Infected with Hepatis C Virus at Tokai University HospitalShunji Hirose, Kota Tsuruya, Yoshimasa Shimma, et al.
Clinical Drug Investigation|April 18, 2019
Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes MellitusYoshitaka Arase, Koichi Shiraishi, Kazuya Anzai, et al.
BMJ Open Gastroenterology|April 21, 2023
First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptanKota Tsuruya, Jun Koizumi, Yuka Sekiguchi, et al.
Pageof 5